Abstract
Numerous reports suggest that use of nonsteroidal anti-inflammatory drugs (NSAIDs) decrease mortality from colorectal cancer. To better understand all of the mechanisms underlying this effect, the global pattern of gene expression in colon carcinoma cells following treatment with NS-398, a selective cyclo-oxygenase-2 inhibitor was evaluated. We utilized suppression subtractive hybridization combined with differential screening to identify genes whose expression was affected following treatment. Among the subtracted cDNA fragments confirmed as differentially expressed, there were two which are known to be involved in the regulation of cell adhesion (human FAT and proto-cadherin-7). We identified two other genes whose levels were decreased and these are known to be involved in the regulation of cell proliferation (cyclin K and p-100). We identified additional genes which are involved in different signaling pathways which regulate programmed cell death (Dynamin 2, Pdcd4 and LIP.1). These results provide evidence that some of the effects of NS-398 on carcinoma cells may be due to modulation of genes which regulate programmed cell death, cell proliferation and cell–cell communication. Additional studies are underway to determine the biological function of the novel genes that were identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akopian AN, Wood JN . 1995 J. Biol. Chem. 270: 21264–21270
Chang YW, Jakobi R, McGinty A, Foschi M, Dunn MJ, Sorokin A . 2000 Mol. Cell. Biol. 20: 8571–8579
Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S, Colburn NH . 1999 Proc. Natl. Acad. Sci. USA 96: 14037–14042
Deleersnijder W, Hong G, Cortvrindt R, Poirier C, Tylzanowski P, Pittois K, Van Marck E, Merregaert J . 1996 J. Biol. Chem. 271: 19475–19482
Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD . 1996 Proc. Natl. Acad. Sci. USA 93: 6025–6030
Drmanac R, Drmanac S . 1999 Methods Enzymol. 303: 165–178
DuBois RN, Radhika A, Reddy BS, Entingh AJ . 1996 Gastroenterology 110: 1259–1262
Dunne J, Hanby AM, Poulsom R, Jones TA, Sheer D, Chin WG, Da SM, Zhao Q, Beverley PC, Owen MJ . 1995 Genomics 30: 207–223
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN . 1994 Gastroenterology 107: 1183–1188
Edwards MC, Wong C, Elledge SJ . 1998 Mol. Cell. Biol. 18: 4291–4300
Fish KN, Schmid SL, Damke H . 2000 J. Cell. Biol. 150: 145–154
Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B . 1996 Biochem. Pharmacol. 52: 237–245
Hara A, Yoshimi N, Niwa M, Ino N, Mori H . 1997 Jpn. J. Cancer Res. 88: 600–604
He TC, Chan TA, Vogelstein B, Kinzler KW . 1999 Cell 99: 335–345
Heidebrecht HJ, Buck F, Steinmann J, Sprenger R, Wacker HH, Parwaresch R . 1997 Blood 90: 226–233
Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA . 2000 Cancer Res. 60: 5040–5044
Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS . 1999 Nat. Med. 5: 1418–1423
Kinoshita T, Takahashi Y, Sakashita T, Inoue H, Tanabe T, Yoshimoto T . 1999 Biochim. Biophys. Acta 1438: 120–130
Kopp E, Ghosh S . 1994 Science 265: 956–959
Kuang WW, Thompson DA, Hoch RV, Weigel RJ . 1998 Nucleic Acids Res. 26: 1116–1123
Kuroda S, Tokunaga C, Kiyohara Y, Higuchi O, Konishi H, Mizuno K, Gill GN, Kikkawa U . 1996 J. Biol. Chem. 271: 31029–31032
Landis SH, Murray T, Bolden S, Wingo PA . 1999 CA Cancer J. Clin. 49: 8–31
Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA . 1997 J. Biol. Chem. 272: 3406–3410
Liang P, Pardee AB . 1992 Science 257: 967–971
Lisitsyn N, Lisitsyn N, Wigler M . 1993 Science 259: 946–951
Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC . 2000 J. Urol. 164: 820–825
Liu XH, Yao S, Kirschenbaum A, Levine AC . 1998 Cancer Res. 58: 4245–4249
Mahoney PA, Weber U, Onofrechuk P, Biessmann H, Bryant PJ, Goodman CS . 1991 Cell 67: 853–868
Maser RL, Calvet JP . 1995 Semin. Nephrol. 15: 29–42
McGinty A, Chang YW, Sorokin A, Bokemeyer D, Dunn MJ . 2000 J. Biol. Chem. 275: 12095–12101
Nagase T, Miyajima N, Tanaka A, Sazuka T, Seki N, Sato S, Tabata S, Ishikawa K, Kawarabayasi Y, Kotani H. et al . 1995 DNA Res. 2: 51–59
Nakagawa N, Hoshijima M, Oyasu M, Saito N, Tanizawa K, Kuroda S . 2000 Biochem. Biophys. Res. Commun. 272: 505–512
Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M . 1999 Jpn. J. Cancer Res. 90: 1152–1162
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM . 1996 Cell 87: 803–809
Rioux N, Castonguay A . 1998 Cancer Res. 58: 5354–5360
Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M . 1998 Am. J. Physiol. 274: G1061–G1067
Serra-Pages C, Kedersha NL, Fazikas L, Medley Q, Debant A, Streuli M . 1995 EMBO J. 14: 2827–2838
Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN . 1997 J. Clin. Invest. 99: 2254–2259
Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T . 1995 Gene 166: 297–301
Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM . 2000 J. Natl. Cancer. Inst. 92: 1136–1142
Smith M, Hawcroft G, Hull MA . 2000 Eur. J. Cancer 36: 664–674
Thun MJ, Namboodiri MM, Heath Jr CW . 1991 N. Engl. J. Med. 325: 1593–1596
Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, Kamada T . 1996 Prostagland. Leukot. Essent. Fatty Acids 55: 179–183
Tsujii M, DuBois RN . 1995 Cell 83: 493–501
Tsujii M, Kawano S, DuBois RN . 1997 Proc. Natl. Acad. Sci. USA 94: 3336–3340
Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN . 1998 Cell 93: 705–716
von Stein OD, Thies WG, Hofmann M . 1997 Nucleic Acids Res. 25: 2598–2602
Wang X, Weng LP, Yu Q . 2000 Oncogene 19: 2346–2353
Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, Yamamoto H, Maruyama T, Kondo K, Ushikubi F, Narumiya S, Sugimura T, Wakabayashi K . 1999 Cancer Res. 59: 5093–5096
Wechter WJ, Kantoci D, Murray Jr ED, Quiggle DD, Leipold DD, Gibson KM, McCracken JD . 1997 Cancer Res. 57: 4316–4324
Weng LP, Wang X, Yu Q . 1999 Genes Cells 4: 185–196
Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, DuBois RN . 1996 Gastroenterology 111: 1134–1140
Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN . 2000a J. Clin. Invest. 105: 1589–1594
Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN . 2000b Cancer Res. 60: 6045–6051
Yin MJ, Yamamoto Y, Gaynor RB . 1998 Nature 396: 77–80
Yoshida K, Yoshitomo-Nakagawa K, Seki N, Sasaki M, Sugano S . 1998 Genomics 49: 458–461
Yoshimi N, Shimizu M, Matsunaga K, Yamada Y, Fujii K, Hara A, Mori H . 1999 Jpn J. Cancer Res. 90: 406–412
Zeng J, Gorski RA, Hamer D . 1994 Nucleic Acids Res. 22: 4381–4385
Zhang X, Morham SG, Langenbach R, Young DA . 1999 J. Exp. Med. 190: 451–459
Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schafer R . 2000 Nat. Genet. 24: 144–152
Acknowledgements
This work was supported in part from the United States Public Health Services Grants DK47297 (RN Dubois), P0 CA77839 (RN Dubois), P30 CA68485 (RN Dubois). RN Dubois is a recipient of a Veterans Affairs Research Merit Grant. We acknowledge the TJ Martell Foundation and the NCCRA for their generous support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, Z., DuBois, R. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20, 4450–4456 (2001). https://doi.org/10.1038/sj.onc.1204588
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204588
Keywords
This article is cited by
-
The growth inhibitory effect of gambogic acid on pancreatic cancer cells
Naunyn-Schmiedeberg's Archives of Pharmacology (2018)
-
Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer
Tumor Biology (2015)
-
Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma
British Journal of Cancer (2013)
-
FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells
Oncogene (2013)
-
Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers
Tumor Biology (2013)